HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 18 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $8,000 | -50.0% | 22,700 | 0.0% | 0.00% | – |
Q2 2020 | $16,000 | +128.6% | 22,700 | 0.0% | 0.00% | – |
Q1 2020 | $7,000 | -56.2% | 22,700 | 0.0% | 0.00% | – |
Q4 2019 | $16,000 | -27.3% | 22,700 | -30.2% | 0.00% | – |
Q3 2019 | $22,000 | -58.5% | 32,507 | +2.0% | 0.00% | – |
Q2 2019 | $53,000 | -65.6% | 31,862 | -48.4% | 0.00% | – |
Q1 2019 | $154,000 | +2.0% | 61,796 | +4.0% | 0.00% | – |
Q4 2018 | $151,000 | +31.3% | 59,438 | +161.8% | 0.00% | – |
Q3 2018 | $115,000 | +55.4% | 22,700 | 0.0% | 0.00% | – |
Q2 2018 | $74,000 | -9.8% | 22,700 | 0.0% | 0.00% | – |
Q1 2018 | $82,000 | -76.2% | 22,700 | -54.4% | 0.00% | – |
Q1 2017 | $345,000 | – | 49,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 5,790,269 | $3,848,000 | 3.74% |
PERKINS CAPITAL MANAGEMENT INC | 2,353,153 | $1,564,000 | 1.35% |
Diametric Capital, LP | 269,822 | $179,000 | 0.15% |
Nantahala Capital Management | 5,000,000 | $3,323,000 | 0.12% |
Sio Capital Management, LLC | 300,000 | $199,000 | 0.06% |
Cowen Prime Services LLC | 100,000 | $66,000 | 0.03% |
Fondren Management LP | 40,375 | $27,000 | 0.02% |
Kalos Management, Inc. | 66,900 | $46,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,387,665 | $922,000 | 0.01% |
Hayden Royal, LLC | 12,000 | $8,000 | 0.01% |